Epidemiology of rosacea described in United Kingdom

May 21, 2012

(HealthDay) -- The incidence of rosacea in the United Kingdom is 1.65 per 1,000 person-years, with alcohol consumption linked to a modest increase in risk and current smoking linked to an decreased risk, according to a study published online May 5 in the British Journal of Dermatology.

To quantify the and describe the demographic characteristics of rosacea, Julia Spoendlin, from the University of Basel in Switzerland, and colleagues used the U.K.-based General Practice Research Database to identify 60,042 patients with a new diagnosis of rosacea between 1995 and 2009 and matched them to 60,042 rosacea-free control patients.

The researchers found that, in the United Kingdom, the overall incidence rate for rosacea was 1.65 per 1,000 person-years. In 80 percent of cases, diagnosis occurred after the age of 30 years. In 20.8 percent of cases, ocular symptoms were noted at the index date. Current smokers had a significantly reduced relative risk of developing rosacea (odds ratio, 0.64), while there was a marginally increased risk seen for .

"This large observational study describes the epidemiology of rosacea in a large sample of the U.K. population and quantifies the presence of ocular involvement in this skin disease," the authors write. "Our findings suggest that smoking may substantially reduce the risk of developing rosacea, whereas alcohol consumption is associated with only a small increase in risk."

One author disclosed to Galderma, which funded the study.

Explore further: The effects of smoking and alcohol use on risk of upper aero-digestive cancers

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

In Taiwan, diabetes linked to increased Parkinson's risk

April 2, 2012

(HealthDay) -- Individuals with diabetes in Taiwan have a significantly increased risk of Parkinson's disease (PD), which is robust across most age and gender stratifications, according to a study published online March 19 ...

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

Arthritis drug may help with type of hair loss

September 22, 2016

(HealthDay)—For people who suffer from a condition that causes disfiguring hair loss, a drug used for rheumatoid arthritis might regrow their hair, a new, small study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.